Found: 16
Select item for more details and to access through your institution.
The effects of antifungal agents on the morphogenetic transformation by Candida albicans in vitro.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Spectrophotometric determination of the morphogenetic transformation by synchronous Candida albicans: effects of antifungal agents.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate microspheres.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 4, p. 673, doi. 10.1007/s10096-017-3159-5
- By:
- Publication type:
- Article
2104. Susceptibility Trends in Antifungal Resistance (STAR) Study: Preliminary Data from A New Prospective Antifungal Surveillance Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S712, doi. 10.1093/ofid/ofz360.1784
- By:
- Publication type:
- Article
704. Incidence and Patient Outcomes of S. aureus Isolates from Acute Bacterial Skin and Skin Structure Infections (ABSSSI) with High Iclaprim MIC values in Phase 3 REVIVE Trials.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S318, doi. 10.1093/ofid/ofz360.772
- By:
- Publication type:
- Article
A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 11, p. 1335, doi. 10.3390/ph6111335
- By:
- Publication type:
- Article
In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 7, p. 1096, doi. 10.3390/antibiotics12071096
- By:
- Publication type:
- Article
In Vitro and In Vivo Antimicrobial Activity of the Novel Peptide OMN6 against Multidrug-Resistant Acinetobacter baumannii.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 9, p. 1201, doi. 10.3390/antibiotics11091201
- By:
- Publication type:
- Article
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 2, p. 200, doi. 10.3390/antibiotics11020200
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy—SMART 2017–2021.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 7, p. 1343, doi. 10.1007/s10096-024-04756-4
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 3, p. 365, doi. 10.1007/s10096-023-04549-1
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)--SMART 2017-21.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 4, p. 1, doi. 10.1093/jacamr/dlad098
- By:
- Publication type:
- Article
In vitro activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa collected from patients with lower respiratory tract infections in Western Europe: SMART 2018-20
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 1, p. 1, doi. 10.1093/jacamr/dlad003
- By:
- Publication type:
- Article
Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0274815
- By:
- Publication type:
- Article
Activity of imipenem/relebactam against MDR Pseudomonas aeruginosa in Europe: SMART 2015-17.
- Published in:
- 2019
- By:
- Publication type:
- journal article
In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.
- Published in:
- 2018
- By:
- Publication type:
- journal article